X

SUNY Canton professor $50,000 winner of SUNY Startup Summer School

Posted 8/14/23

CANTON – A SUNY Canton professor was named one of two $50,000 winners of the SUNY Startup Summer School (S4) Class of 2023 Demo Day, the State University of New York reports. Kambiz Ghazinour, …

This item is available in full to subscribers.

Please log in to continue

Log in

SUNY Canton professor $50,000 winner of SUNY Startup Summer School

Posted

CANTON – A SUNY Canton professor was named one of two $50,000 winners of the SUNY Startup Summer School (S4) Class of 2023 Demo Day, the State University of New York reports.

Kambiz Ghazinour, CyberSpara founder and Associate Professor and Director of the Advanced Information Security and Privacy (AISP) Research Lab, was chosen regarding DigitalPASS, a scenario-based simulation platform that helps individuals and organizations to stay safe online.

"Congratulations to Associate Professor Kambiz Ghazinour for his remarkable achievement in winning the SUNY Startup Summer School Class of 2023 Demo Day. Dr. Ghazinour's innovative work exemplifies the spirit of entrepreneurship and innovation that SUNY Canton fosters. We are proud to have Dr. Ghazinour as a part of our academic community, and his success inspires our students and faculty. Here's to a future where technology and education combine for a safer digital world,” said SUNY Canton President Zvi Szafran.

SUNY Startup Summer School is a competitive program designed to showcase the most promising technologies and startups being developed by participants, including 179 SUNY students, faculty, and staff in emerging technologies fields spanning 27 different SUNY campuses. The SUNY Startup Summer School, now in its fifth year, offers entrepreneurial education and training to help students and faculty secure the initial funding needed to get their technology to market.

The second winners is DUB Biologics from Upstate Medical University

Headed by co-founders Professor Audrey Bernstein and Research Associate Tere Williams; regarding siRNA therapeutic that increases the rate of wound closure and protects against pathogenic infection that may contribute to scarring.

In addition to the capital received from the SUNY Technology Accelerator Fund Catalyst Investment, DUB Biologics and CyberSpara will also receive secondary support from SUNY to identify and write strong proposals for grant funding, which will allow the teams to continue commercializing their technology.